# Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors

> **NCT00066651** · PHASE1 · COMPLETED · sponsor: **National Cancer Institute (NCI)**

## Conditions studied

- Cervical Cancer
- Fallopian Tube Cancer
- Head and Neck Cancer
- Lung Cancer
- Malignant Mesothelioma
- Ovarian Cancer
- Pancreatic Cancer
- Primary Peritoneal Cavity Cancer

## Interventions

- **BIOLOGICAL:** SS1(dsFv)-PE38 immunotoxin

## Key facts

- **NCT ID:** NCT00066651
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-07
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2015-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00066651

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00066651, "Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT00066651. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*